Skip to main content
. 2024 Sep 13;8:1394. Originally published 2019 Aug 8. [Version 7] doi: 10.12688/f1000research.19931.7

Table 2. Results 1 of THC analysis in commercial hemp-based products from the German market (2018–2023).

Year Samples with Δ 9-THC
content exceeding LOAEL
Samples with Δ 9-THC content
between ARfD and LOAEL
Sample with Δ 9-THC
content below ARfD
Samples
(total)
2018 7 (78%) 2 (22%) 0 (0%) 9
2019 10 (16%) 30 (47%) 24 (38%) 64
2020 4 (4%) 49 (46%) 54 (50%) 107
2021 7 (6%) 50 (44%) 56 (50%) 113
2022 11 (16%) 33 (48%) 25 (36%) 69
2023 9 (18%) 21 (41%) 21 (41%) 51
2018–2023 (total) 48 (12%) 185 (45%) 180 (44%) 413

1 For raw results see dataset 31 , table sheet 2.

Abbreviations: Δ 9-THC: Δ 9-tetrahydrocannabinol; ARfD: acute reference dose of 1 μg THC per kg body weight 33 ; LOAEL: lowest observed adverse effect level of 2.5 mg Δ 9-THC per day 33